Skip to content Skip to navigation

People

Dr. Mahajan’s lab provides an immersive,  intensive training environment for students and fellows to discover the molecular mechanisms that cause blindness and develop therapies to prevent vision loss. Highly collaborative research teams are made up of scientists, surgeons, and engineers from around the world, interacting on a daily basis and using advanced scientific methods.

Affiliated Faculty

Stephen Tsang M.D., Ph.D.

Steve has been collaborating with the Mahajan Lab since 2008. He is a Laszlo T. Bito Associate Professor of Ophthalmology and Associate Professor of Pathology and Cell Biology at Columbia University. Steve is a pioneer in genome surgery in stem cells. His research focuses on reprogramming the metabolome as a therapy for patients with retinal degeneration. His expertise includes Genetic Disorders, Genetic Testing, Pediatric Genetics, Retinal Disorders, Eye Genetics, Clinical Genetics, Adult Genetics, Retinopathy, Marfan's Syndrome, and Macular Degeneration.

Mayank Bansal

Mayank is a vitreoretinal surgeon. He completed his residency in ophthalmology at the All India Institute of Medical Sciences and then spent a year at the University of Iowa in 2014. Upon certification by the International Council of Ophthalmology, he was awarded a scholarship for fellowship in vitreoretinal surgery by ICO at University of California, Los Angeles. His research focuses on Diabetic Retinopathy, macular degeneration, complex vitreoretinal surgeries, and innovations in ophthalmology. 

Alexander G. Bassuk M.D., Ph.D.

Alex has been a key collaborator with the Mahajan Lab since 2012. He is  a pediatric neurologist at the University of Iowa whose laboratory focuses on the molecular biology, protein biochemistry, and genetic mechanisms in human diseases and in animal models.  Along with a diverse cross-disciplinary team of researchers, he is pursuing a collaborative and innovative approach to use proteomics, fruit flies, zebrafish, and mice to rapidly translate basic science findings into clinical treatments. His investigational group is well poised to leverage novel in vivo techniques into new treatments for epilepsy and other human diseases. 

Yang Sun M.D., Ph.D.

Dr. Yang Sun is a clinician-scientist in glaucoma and an Associate Professor of Ophthalmology at Stanford University and Byers Eye Institute. Dr. Sun received his B.A. in Biophysics from Johns Hopkins University, followed by an M.D., Ph.D. from Washington University School of Medicine.  He completed Ophthalmology residency at Stanford University and a prestigious Heed fellowship at the University of Michigan, Ann Arbor. He has been funded by the National Eye Institute, Veterans Administration, American Glaucoma Society, Lowe Syndrome Association, Knights Templar Eye Foundation, and Matilda Ziegler Foundation.  Dr. Sun holds several U.S. patents on novel regulators of eye pressure and is the primary investigator on a number of glaucoma clinical trials.